Advancements in nanosensors for an early detection of cancer

Abstract

Nanosensors are highly adaptable analytical tools with a vast potential for disease diagnosis, especially for cancer detection. Their effectiveness relies on multiple factors, including synthesis, material diversity, and transduction methods. This versatility opens doors to various applications, such as cancer biomarker detection, high-resolution bioimaging, and the development of compact, portable diagnostic devices. In addition, new avenues are emerging in nanosensors, notably through advanced domains, such as micro/nanorobotics and artificial intelligence (AI). Over the years, nanosensors have undergone transformative evolution, offering a wide array of applications, particularly in cancer detection. Due to their high specificity and sensitivity, these devices are extensively used for detecting various biomolecules and cancer-specific markers. One of the most remarkable features of nanosensors is their adaptability. Researchers can customize their composition, size, and surface properties, enabling the design of highly specific nanosensors to certain cancer biomarkers, thus reducing the risk of false results. Nanosensors are at the forefront of modern medical research. Their ability to seamlessly integrate traditional diagnostics with advanced technologies, such as AI, holds promise for reshaping healthcare. As researchers continue to enhance their capabilities and uncover new applications, nanosensors are poised to redefine disease diagnosis and treatment, paving the way for groundbreaking advances.